aspirin and tp 9201

aspirin has been researched along with tp 9201 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baughman, SA; Modi, NB; Paasch, BD; Reynolds, T; Smith, SY; Thomas, DA	1

Other Studies

1 other study(ies) available for aspirin and tp 9201

Article	Year
Pharmacokinetics and pharmacodynamics of TP-9201, a gpIIbIIIa antagonist, administered in combination with recombinant tissue-type plasminogen activator, heparin, and aspirin in beagles. Journal of cardiovascular pharmacology, 1996, Volume: 27, Issue:1 Topics: Animals; Anticoagulants; Aspirin; Dogs; Drug Therapy, Combination; Heparin; Male; Peptides, Cyclic; Plasminogen Activators; Platelet Aggregation; Platelet Aggregation Inhibitors; Tissue Plasminogen Activator	1996

Article

Year

Pharmacokinetics and pharmacodynamics of TP-9201, a gpIIbIIIa antagonist, administered in combination with recombinant tissue-type plasminogen activator, heparin, and aspirin in beagles.

Journal of cardiovascular pharmacology, 1996, Volume: 27, Issue:1

Topics: Animals; Anticoagulants; Aspirin; Dogs; Drug Therapy, Combination; Heparin; Male; Peptides, Cyclic; Plasminogen Activators; Platelet Aggregation; Platelet Aggregation Inhibitors; Tissue Plasminogen Activator

1996